SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-008018
Filing Date
2019-08-13
Accepted
2019-08-13 08:21:37
Documents
71
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ruby-20190630x10q.htm 10-Q 2503252
2 EX-10.1 ruby-20190630ex101c4a143.htm EX-10.1 120196
3 EX-31.1 ruby-20190630ex311b1eb7a.htm EX-31.1 12742
4 EX-31.2 ruby-20190630ex312aba031.htm EX-31.2 12593
5 EX-32.1 ruby-20190630ex32134bc89.htm EX-32.1 8126
6 EX-32.2 ruby-20190630ex322369fbd.htm EX-32.2 8086
  Complete submission text file 0001558370-19-008018.txt   8303578

Data Files

Seq Description Document Type Size
7 EX-101.INS ruby-20190630.xml EX-101.INS 1700603
8 EX-101.SCH ruby-20190630.xsd EX-101.SCH 49594
9 EX-101.CAL ruby-20190630_cal.xml EX-101.CAL 56356
10 EX-101.DEF ruby-20190630_def.xml EX-101.DEF 186917
11 EX-101.LAB ruby-20190630_lab.xml EX-101.LAB 479752
12 EX-101.PRE ruby-20190630_pre.xml EX-101.PRE 359940
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38586 | Film No.: 191018297
SIC: 2836 Biological Products, (No Diagnostic Substances)